Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
DRL, Emcure get approval to make breakthrough HIV drug - The Economic Times
India's drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for local clinical trials. This move will improve access to the HIV prevention injection. Lenacapavir is a breakthrough twice-yearly injection for HIV prevention. Patient groups had urged the regulator to expedite this process.
Ähnliche Seiten
Indian pharma has little reason to fear Trump - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-pharma-has-little-reason-to-fear-trump/articleshow/133449610.cmsNovo Nordisk uses AI to fast-track drug launches, expand India role - The Economic Times
https://economictimes.indiatimes.com/tech/artificial-intelligence/novo-nordisk-uses-ai-to-fast-track-drug-launches-expand-india-role/articleshow/131278271.cmsSun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028 - The Economic Times
https://economictimes.indiatimes.com/markets/stocks/news/sun-pharma-cipla-other-pharma-stocks-in-focus-as-trump-unveils-100-200-tariffs-on-generic-drugs-from-2028/articleshow/132550249.cmsRegulator mandates full review of globally unapproved drugs - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/regulator-mandates-full-review-of-globally-unapproved-drugs/articleshow/133164531.cmsDr Reddy’s pauses weight loss drug on quality fears - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-pauses-weight-loss-drug-on-quality-fears/articleshow/132297324.cms